61755-014Level 3
VEOPOZ (Pozelimab)
**Product type:** Human Prescription Drug
**Active ingredient:** POZELIMAB
**Strength:** 200 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous; Subcutaneous
**Labeler:** Regeneron Pharmaceuticals, Inc.
**Marketing category:** BLA (BLA761339)
**Pharmacologic class:** Complement Inhibitor [EPC], Complement Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/61755-014Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.